Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs IQVIA Holdings Inc. Common Stock (IQV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs IQVIA Holdings Inc. Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while IQVIA Holdings Inc. Common Stock trades at $259.88 (market cap $42.61B). The key difference: IQVIA Holdings Inc. Common Stock is far larger — about 7.1× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, IQVIA Holdings Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and IQVIA Holdings Inc. Common Stock for 1 Days on average.
| IOVA | IQV | |
|---|---|---|
Market Cap | $6.04B | $42.61B |
Volume | 14,805,993 | 988,398 |
Sector | Health | Health |
52-Week High | $14.82 | $275.02 |
52-Week Low | $1.81 | $156.66 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $5.97B | $56.77B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About IQVIA Holdings Inc. Common Stock
IQVIA provides clinical research, healthcare data, technology, and consulting services to life sciences companies. Its work supports drug development and commercialization.
Read more on IQV →
